Pharmacoepidemiology & Medication Adherence

Our overall goal in conducting pharmacoepidemiology and medication adherence studies at Kaiser Permanente Colorado is to improve the health outcomes of our members and the larger community. Pharmacoepidemiology is the study of the uses, effects, and risks of drugs in large numbers of people. Medication adherence is the extent to which a person's medication-taking behavior corresponds to that which was prescribed or advised by a medical professional. To carry out our research goals, we collaborate with KPCO leaders and clinicians, as well as with other Kaiser Permanente regions and integrated healthcare delivery organizations. We also team up with national organizations such as the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Through observational and interventional studies, we identify, quantify, and work to minimize drug adverse effects, maximize drug benefits, and improve medication adherence. We contribute data and expertise that impact medical product policy in the US.


Recent Publications

Pharmacoepidemiology & Medication Adherence Researchers

  • Marsha A. Raebel, PharmD
    Senior Investigator

Featured Projects